Medicine, Dermatology and Toxicology
Department
Hospital Sierrallana
Torrelavega, EspañaPublications in collaboration with researchers from Hospital Sierrallana (6)
2021
-
Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation
BMC Cardiovascular Disorders, Vol. 21, Núm. 1
-
European registry on helicobacter pylori management: Effectiveness of first and second-line treatment in Spain
Antibiotics, Vol. 10, Núm. 1, pp. 1-15
-
Methylprednisolone in adults hospitalized with COVID-19 pneumonia : An open-label randomized trial (GLUCOCOVID)
Wiener klinische Wochenschrift, Vol. 133, Núm. 7-8, pp. 303-311
2010
-
Power doppler ultrasonography assessment of entheses in spondyloarthropathies: Response to therapy of entheseal abnormalities
Journal of Rheumatology, Vol. 37, Núm. 10, pp. 2110-2117
2008
-
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903
Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092
2003
-
Distribución de la enfermedad polipoidea en la comarca interior de Vizcaya: Implicación en pruebas diagnósticas y cribado del cáncer colorrectal
Gastroenterologia y Hepatologia, Vol. 26, Núm. 7, pp. 401-406